Table 1.
Patient characteristics and tumor identification and staging
| Control | PDAC | NRPT | BDAC | AC | EC | CP | |
|---|---|---|---|---|---|---|---|
| N Patients Pre surg. | 20 | 25 | 6 | 4 | 6 | 5 | 7 |
| N Patients Post surg. | N/A | 16 | 6 | 4 | 6 | ||
| Males | 12 | 15 | 5 | 3 | 6 | 2 | 3 |
| Females | 8 | 10 | 1 | 1 | 0 | 3 | 4 |
| Median age (range) | 66 (49-86) | 68 (47-78) | 66 (51-74) | 75 (65-78) | 67 (53-75) | 58 (46-67) | 67 (59-72) |
| TNM | |||||||
| 1A | 1 | 3 | |||||
| 1B | 4 | 1 | 3 | 1 | |||
| 2A | 1 | 1 | |||||
| 2B | 19 | 3 | 1 | ||||
| 3 | 1 | ||||||
| 4 | 1 | ||||||
| Differentiation | |||||||
| G1 | 5 | 2 | 2 | ||||
| G2 | 13 | 1 | 3 | ||||
| G3 | 7 | 3 | |||||
| Not evaluated | 1 | 3 |
Pancreatic ductal adenocarcinoma (PDAC), None resectable pancreatic tumor (NRPT), billary duct adenocarcinoma (BDCA), ampullary carcinoma (AC), endocrine carcinoma (EC), chronic pancreatitis (CP), not applicable (N/A), Tumour, Node, Metastasis (TNM), number (N)